I am an accomplished structural biologist with a wealth of experience in X-ray crystallography, protein modeling, data collection, structure refinement and target selection. I have showcased strong leadership abilities in multiple gene-to-structure and drug discovery programs. Throughout my career, I have contributed significantly:• Determining over 640 co-crystal structures• Publishing over 35 peer-reviewed articles• Depositing 55+ entries in the PDB• Securing 10 U.S. patentsMy expertise spans across diverse therapeutic areas including antimicrobials, metabolic, oncology, neuroscience, GI and rare diseases disorders. I have worked extensively with various target classes, including kinases, metalloproteases, ubiquitin ligases, nucleotidyltransferases and more.Awards:• 2020 R&D Project Team Award recipient recognized as a member of the COVID-19 research project team, selected by the R&D Management Committee. The R&D Project Team Award recognizes teams and individuals who worked incredibly hard and delivered impactful, enterprise-wide results for our organization outside of their defined role. Awards are given to employees supporting projects that align with KPI focus areas of Pipeline, Operational Effectiveness and Transformation. • 2019 Q3 POP! Award (Pipeline) recipient recognition and thank you for making such great strides in enabling several protein targets with structural information. • 2005 Takeda Global Award recipient yearly award to recognize employees from the entire Takeda global organizations who have made outstanding accomplishments.• 2002 C.A.I.K. Award Syrrx Inc. recipient (quarterly award given by peers to the employee who best displays company values of collaborative synergy, action, innovation and knowledge.